PortfoliosLab logoPortfoliosLab logo
SPRY vs. STZ
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

SPRY vs. STZ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Silverback Therapeutics Inc (SPRY) and Constellation Brands, Inc. (STZ). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, SPRY achieves a -53.13% return, which is significantly lower than STZ's -2.76% return.


SPRY

1D
6.43%
1M
-36.21%
6M
-46.99%
YTD
-53.13%
1Y
-68.22%
3Y*
-8.08%
5Y*
-28.53%
10Y*
ALL TIME*
-25.54%

STZ

1D
0.87%
1M
-3.69%
6M
-14.38%
YTD
-2.76%
1Y
-18.64%
3Y*
-19.32%
5Y*
-7.99%
10Y*
-0.52%
ALL TIME*
14.32%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$17.38M$14.89M$16.09M
$254.34M$279.34M$313.22M

SPRY vs. STZ - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
SPRY
Silverback Therapeutics Inc
-53.13%10.43%92.52%-35.76%28.08%-85.63%59.79%
STZ
Constellation Brands, Inc.
-2.76%-35.99%-7.11%5.83%-6.43%16.12%4.42%

Correlation

The correlation between SPRY and STZ is 0.05, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.05

Correlation (3Y)
Balances recent behavior with more history.

0.07

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.11

Correlation (All Time)
Calculated using the full available price history since Dec 4, 2020

0.10

Fundamentals

Market Cap

SPRY:

$542.20M

STZ:

$22.44B

EPS

SPRY:

-$2.00

STZ:

$10.48

PS Ratio

SPRY:

5.45

STZ:

2.53

PB Ratio

SPRY:

8.84

STZ:

2.65

Total Revenue (TTM)

SPRY:

$98.99M

STZ:

$9.06B

Gross Profit (TTM)

SPRY:

$59.93M

STZ:

$4.77B

EBITDA (TTM)

SPRY:

-$194.60M

STZ:

$3.18B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SPRY vs. STZ — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

SPRY
SPRY Risk / Return Rank: 55
Overall Rank
SPRY Sharpe Ratio Rank: 55
Sharpe Ratio Rank
SPRY Sortino Ratio Rank: 55
Sortino Ratio Rank
SPRY Omega Ratio Rank: 66
Omega Ratio Rank
SPRY Calmar Ratio Rank: 44
Calmar Ratio Rank
SPRY Martin Ratio Rank: 66
Martin Ratio Rank

STZ
STZ Risk / Return Rank: 1616
Overall Rank
STZ Sharpe Ratio Rank: 1616
Sharpe Ratio Rank
STZ Sortino Ratio Rank: 1616
Sortino Ratio Rank
STZ Omega Ratio Rank: 1818
Omega Ratio Rank
STZ Calmar Ratio Rank: 1616
Calmar Ratio Rank
STZ Martin Ratio Rank: 1616
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

SPRY vs. STZ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Silverback Therapeutics Inc (SPRY) and Constellation Brands, Inc. (STZ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


SPRYSTZDifference
Sharpe ratioReturn per unit of total volatility

-0.33

Sortino ratioReturn per unit of downside risk

-0.92

Omega ratioGain probability vs. loss probability

0.81

0.91

-0.11

Calmar ratioReturn relative to maximum drawdown

-0.96

-0.73

-0.23

Martin ratioReturn relative to average drawdown

-1.42

-1.16

-0.26

SPRY vs. STZ - Sharpe Ratio Comparison

The current SPRY Sharpe Ratio is -0.95, which is lower than the STZ Sharpe Ratio of -0.62. The chart below compares the historical Sharpe Ratios of SPRY and STZ, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

SPRY vs. STZ - Drawdown Comparison

The maximum SPRY drawdown since its inception was -95.20%, which is greater than STZ's maximum drawdown of -67.39%. Use the drawdown chart below to compare losses from any high point for SPRY and STZ.


Loading charts...

Drawdown Indicators


SPRYSTZDifference

Max Drawdown

Largest peak-to-trough decline

-95.20%

-67.39%

-27.81%

Max Drawdown (1Y)

Largest decline over 1 year

-71.47%

-25.73%

-45.74%

Max Drawdown (3Y)

Largest decline over 3 years

-72.04%

-51.28%

-20.76%

Max Drawdown (5Y)

Largest decline over 5 years

-90.62%

-51.28%

-39.34%

Max Drawdown (10Y)

Largest decline over 10 years

-53.53%

Current Drawdown

Current decline from peak

-90.96%

-48.81%

-42.15%

Average Drawdown

Average peak-to-trough decline

-78.45%

-16.72%

-61.73%

Ulcer Index

Depth and duration of drawdowns from previous peaks

47.94%

16.05%

+31.89%

Volatility

SPRY vs. STZ - Volatility Comparison

Silverback Therapeutics Inc (SPRY) has a higher volatility of 15.51% compared to Constellation Brands, Inc. (STZ) at 8.57%. This indicates that SPRY's price experiences larger fluctuations and is considered to be riskier than STZ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


SPRYSTZDifference

Volatility (1M)

Calculated over the trailing 1-month period

15.51%

8.57%

+6.94%

Volatility (6M)

Calculated over the trailing 6-month period

49.67%

22.81%

+26.86%

Volatility (1Y)

Calculated over the trailing 1-year period

71.94%

30.28%

+41.66%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

80.63%

24.91%

+55.72%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

81.14%

27.09%

+54.05%

Dividends

SPRY vs. STZ - Dividend Comparison

SPRY has not paid dividends to shareholders, while STZ's dividend yield for the trailing twelve months is around 3.12%.


PositionTTM20252024202320222021202020192018201720162015
SPRY
Silverback Therapeutics Inc
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
STZ
Constellation Brands, Inc.
3.12%2.95%1.77%1.44%1.36%1.21%1.37%1.58%1.70%0.86%0.98%0.65%

Financials

SPRY vs. STZ - Financials Comparison

This section allows you to compare key financial metrics between Silverback Therapeutics Inc and Constellation Brands, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


SPRY and STZ have a correlation of 0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

SPRY has higher volatility (15.51%) compared to STZ (8.57%). In terms of maximum drawdown, SPRY dropped -95.20% vs STZ's -67.39%.

STZ currently has the higher Sharpe Ratio (-0.62 vs -0.95), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for SPRY and STZ

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer